Terms ending in 2033
Every in-force patent on Immunomedics, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,028,833 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,107,960 | ANTIBODY-SN-38 Immunoconjugates with a CL2A Linker In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,226,973 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,458,242 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,475,884 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,481,732 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,492,566 | Antibody-Drug Conjugates and Uses Thereof In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,493,573 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,499,631 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| US 9,522,959 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force · High confidence | Immunomedics, Inc. | In force | High confidence | |
| 24 more term ends in 2033 · Pro | |||||
10 of 34 patents shown. Soonest term end first, then patent number.
Pro members see all 34.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.